Patents by Inventor David W. Miles

David W. Miles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lisinopril formulations
    Patent number: 12186360
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: May 14, 2024
    Date of Patent: January 7, 2025
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Lisinopril formulations
    Patent number: 12128083
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: August 16, 2023
    Date of Patent: October 29, 2024
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
    Patent number: 11795241
    Abstract: The present invention relates to compositions comprising fractionated alkylated cyclodextrin compositions having a single degree of substitution, and processes for preparing and using the same.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: October 24, 2023
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventors: Vincent D. Antle, Charles Alan Watson, David W. Miles
  • Lisinopril formulations
    Patent number: 11771733
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: October 3, 2023
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Lisinopril formulations
    Patent number: 11179434
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: November 23, 2021
    Assignee: Silvergate Pharmaceuticals Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 11173141
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: November 16, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 11141405
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 12, 2021
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • ENALAPRIL FORMULATIONS
    Publication number: 20210299092
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 30, 2021
    Inventors: Gerold L. Mosher, David W. Miles
  • ENALAPRIL FORMULATIONS
    Publication number: 20210251956
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: April 12, 2021
    Publication date: August 19, 2021
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 11040023
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: June 22, 2021
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • FRACTIONATED ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME
    Publication number: 20210147582
    Abstract: The present invention relates to compositions comprising fractionated alkylated cyclodextrin compositions having a single degree of substitution, and processes for preparing and using the same.
    Type: Application
    Filed: November 24, 2020
    Publication date: May 20, 2021
    Inventors: Vincent D. Antle, Charles Alan Watson, David W. Miles
  • ENALAPRIL FORMULATIONS
    Publication number: 20210137882
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 13, 2021
    Inventors: Gerold L. Mosher, David W. Miles
  • Lisinopril formulations
    Patent number: 10940177
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: March 9, 2021
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 10918621
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: February 16, 2021
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
    Patent number: 10851184
    Abstract: The present invention relates to compositions comprising fractionated alkylated cyclodextrin compositions having a single degree of substitution, and processes for preparing and using the same.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: December 1, 2020
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventors: Vincent D. Antle, Charles Alan Watson, David W. Miles
  • Enalapril formulations
    Patent number: 10799476
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: October 13, 2020
    Assignee: Silvergate Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 10786482
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: September 29, 2020
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Enalapril formulations
    Patent number: 10772868
    Abstract: Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: September 15, 2020
    Assignee: Silvergate Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles
  • Lisinopril formulations
    Patent number: 10406199
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: September 10, 2019
    Assignee: SILVERGATE PHARMACEUTICALS, INC.
    Inventors: Gerold L. Mosher, David W. Miles
  • Lisinopril formulations
    Patent number: 10265370
    Abstract: Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: April 23, 2019
    Assignee: Silvergate Pharmaceuticals, Inc.
    Inventors: Gerold L. Mosher, David W. Miles